Clinical Trial

Cryospray Therapy for Benign Airway Stenosis

Study acronym: CRYOSTASIS
Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a clinical evaluation to assess the effectiveness of cryospray therapy used in addition to current standard of care endoscopic therapies in preventing short term recurrent airway stenosis with a multicentric outcome evaluation. The investigators hypothesize that the addition of SCT to standard endoscopic treatment of benign airway stenosis will result in decreased stenosis recurrence at 6 months as estimated by quantitative radiologic assessment of the stenotic volume.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-10-12; most recent amendment 2025-12-03.
Trial Details
NCT Number NCT06085209
Lead Sponsor Virginia Commonwealth University
Collaborators: US Endoscopy Group Inc.
Conditions Stenosis Trachea
Enrollment 12 participants
Start Date 2023-10-12
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-10